The effect of delay in fixation, different fixatives, and duration of fixation in estrogen and progesterone receptor results in breast carcinoma

American Journal of Clinical Pathology

Volumn 135, Issue 4, 2011, Pages 592-598

  Apple, Sophia ^a   Pucci, Richard ^a   Lowe, Alarice C ^a   Shintaku, Itsushi ^a   Shapourifar Tehrani, Saeedeh ^a   Moatamed, Neda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast carcinoma; Estrogen receptor; Fixation; Fixatives; Progesterone receptor; Time factors

Indexed keywords

ESTROGEN RECEPTOR; FORMALDEHYDE; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CASE REPORT; DIAGNOSTIC ACCURACY; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; FIXATIVES; HUMANS; MEDICAL ONCOLOGY; PATHOLOGY; PRACTICE GUIDELINES AS TOPIC; PRESERVATION, BIOLOGICAL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SOCIETIES, MEDICAL; TIME FACTORS;

EID: 79954585490     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPB1RIT5YXMRIS     Document Type: Article

References (17)

1. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145. (Pubitemid 350003059)
2. Rhodes A, Jasani B, Balaton AJ, et al. Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: Correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol. 2000;53:688-696.
3. Rhodes A, Jasani B, Balaton AJ, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe: Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am J Clin Pathol. 2001;115:44-58. (Pubitemid 33695090)
4. Layfield LJ, Goldstein N, Perkinson KR, et al. Interlaboratory variation in results from immunohistochemical assessment of estrogen receptor status. Breast J. 2003;9:257-259. (Pubitemid 36627180)
5. Khoury T, Sai S, Hwang H, et al. Delay to formalin fixation effect on breast biomarkers. Mod Pathol. 2009;22:1457-1467.
6. Yaziji H, Taylor CT, Goldstein NS, et al. Consensus recommendations of estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol. 2008;16:513-520.
7. Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligandbinding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474-1481. (Pubitemid 29220854)
8. Allred DC. Commentary: Hormone receptor testing in breast cancer: A distress signal from Canada. Oncologist. 2008;13:1134-1136.
9. Gown AM. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol. 2008;21(suppl 2):S8-S15. (Pubitemid 351592775)
10. Hede K. Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing. J Natl Cancer Inst. 2008;100:836-837, 844.
11. Mathews AW. Bad cancer tests drawing scrutiny. Wall Street Journal. January 4, 2008:B1-B2.
12. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, et al. Immunohistochemistry of estrogen and progesterone receptors reconsidered: Experience with 5,993 breast cancers. Am J Clin Pathol. 2005;123:21-27. (Pubitemid 40066168)
13. Bardou VJ, Arpino G, Elledge RM, et al. Progesterone receptor status. J Clin Oncol. 2003;21:1973-1979.
14. Clarke RB. Steroid receptors and proliferation in the human breast. Steroids. 2003;68:789-794. (Pubitemid 37532401)
15. Love RR, Ba NB, Allred DC, et al. Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J Clin Oncol. 2002;20:2559-2566. (Pubitemid 34525744)
16. Mohsin SK, Weiss H, Havighurst T, et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: A validation study. Mod Pathol. 2004;17:1545-1554. (Pubitemid 39627082)
17. Goldstein NS, Ferkowicz M, Odish E, et al. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol. 2003;120:86-92. (Pubitemid 37046374)